Fermata Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Fermata Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,450	Closed	-$798K	–	249
2024 Q1	$798K	Sell	2,450 -600	-20%	-$147K	0.18%	92
2023 Q4	$581K	Hold	3,050	–	–	0.14%	97
2023 Q3	$607K	Buy	+3,050	New	+$721K	0.17%	93
2023 Q2	–	Sell	-2,600	Closed	-$564K	–	117
2023 Q1	$564K	Hold	2,600	–	–	0.34%	57
2022 Q4	$535K	Hold	2,600	–	–	0.16%	91
2022 Q3	$723K	Sell	2,600 -400	-13%	-$102K	0.24%	86
2022 Q2	$574K	Buy	+3,000	New	+$530K	0.2%	92

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Fermata Advisors's SWAV Position: Q2 2024 in Review

Fermata Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 2,450 shares — an estimated $798K sold.

Fermata Advisors first reported a position in SWAV in Q2 2022 and held it in 7 quarters. The position peaked at $798K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Fermata Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Fermata Advisors sold 2,450 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $798K.
Fermata Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
Fermata Advisors's Shockwave Medical, Inc. Common Stock position peaked at $798K in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Fermata Advisors's 13F filing for Q2 2024, filed 12 Jul 2024.